Get started
Author

Salah Aljamal

Observed name: S. Al-Jamal
ORCID: 0000-0003-1514-8772
Observed ORCID: 0000-0003-1514-8772
OpenAlex ID: A5044117648
Kinesin Spindle Protein Inhibitors in Cancer: From High Throughput Screening to Novel Therapeutic Strategies
2022 · Rand Shahin, Salah Aljamal · Future Science OA · 56
QSAR-guided pharmacophoric modeling reveals important structural requirements for Polo kinase 1 (Plk1) inhibitors
2021 · Rand Shahin, Nabil N. AL-Hashimi, et al. · Journal of Molecular Graphics and Modelling · 7
Design and Implementation of Proactive Multi-Type Context-Aware Recommender System for Patients Suffering Diabetes
2023 · A. Abu-Issa, S. Hajjaj, et al. · International Conference on Smart Applications, Communications and Networking (SmartNets) · 6
Cosmeceutical formulations of pro-vitamin E phosphate: In-vitro release testing and dermal penetration into excised human skin
2023 · Mais M. Saleh, Raghad M. Abuhamdan, et al. · International Journal of Pharmaceutics · 6
A comprehensive in-silico approach (pharmacophoric QSAR and docking-based comparative intermolecular analysis) led to identifying new PIM2 kinase inhibitors for treating resistant lymphomas
2025 · Rand Shahin, Sawsan Jaafreh, et al. · Letters in Drug Design & Discovery · 5
Formulation and evaluation of controlled-release, carrageenan-based powder formulations filled into hard gelatin capsules
2023 · Abdullah Barakat, Yahya Abu-Hameda, et al. · Jordan Journal of Pharmaceutical Sciences · 2
PDF
Preparation and characterization of drug-loaded, electrospun nanofiber mats formulated with zein or zein-based mixtures for wound healing applications.
2023 · Salah Aljamal, Shrouq Sotari, et al. · Jordan Journal of Pharmaceutical Sciences · 1
PDF
Works count: 7
Citation count: 83
H-index: 5
I10-index: 1
Year
Topic
Type